• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Proteomic identification of neoadjuvant chemotherapy-related proteins in bulky stage IB-IIA squamous cervical cancer.大体积 IB-IIA 期鳞癌新辅助化疗相关蛋白的蛋白质组学鉴定。
Reprod Sci. 2013 Nov;20(11):1356-64. doi: 10.1177/1933719113485291. Epub 2013 Apr 18.
2
Proteomic identification of predictive tissue biomarkers of sensitive to neoadjuvant chemotherapy in squamous cervical cancer.蛋白质组学鉴定宫颈鳞癌中新辅助化疗敏感的预测性组织生物标志物
Life Sci. 2016 Apr 15;151:102-108. doi: 10.1016/j.lfs.2016.03.006. Epub 2016 Mar 3.
3
Identification of cervical cancer proteins associated with treatment with paclitaxel and cisplatin in patients.鉴定与紫杉醇和顺铂联合治疗患者相关的宫颈癌蛋白。
Int J Gynecol Cancer. 2011 Nov;21(8):1452-7. doi: 10.1097/IGC.0b013e31822491d0.
4
Proteomic identification of differentially-expressed proteins in squamous cervical cancer.宫颈癌鳞状细胞中差异表达蛋白质的蛋白质组学鉴定
Gynecol Oncol. 2009 Jan;112(1):248-56. doi: 10.1016/j.ygyno.2008.09.045. Epub 2008 Nov 13.
5
Expression of thioredoxin 1 and peroxiredoxins in squamous cervical carcinoma and its predictive role in NACT.硫氧还蛋白 1 和过氧化物酶在宫颈鳞癌中的表达及其在新辅助化疗中的预测作用。
BMC Cancer. 2019 Aug 30;19(1):865. doi: 10.1186/s12885-019-6046-x.
6
Candidates for tumor markers of cervical cancer discovered by proteomic analysis.蛋白质组分析发现的宫颈癌肿瘤标志物候选物。
J Korean Med Sci. 2012 Dec;27(12):1479-85. doi: 10.3346/jkms.2012.27.12.1479. Epub 2012 Dec 7.
7
Profiling protein markers associated with the sensitivity to concurrent chemoradiotherapy in human cervical carcinoma.分析与人类宫颈癌同步放化疗敏感性相关的蛋白质标志物。
J Proteome Res. 2009 Aug;8(8):3969-76. doi: 10.1021/pr900287a.
8
Efficacy of neoadjuvant chemotherapy plus radical surgery in patients with bulky stage II cervical squamous cell carcinoma: A retrospective cohort study.新辅助化疗联合根治性手术治疗巨块型 IIB 期宫颈鳞癌的疗效:一项回顾性队列研究。
Int J Surg. 2016 Jun;30:121-5. doi: 10.1016/j.ijsu.2016.04.038. Epub 2016 Apr 27.
9
Immunohistochemical expression of Annexin A2 and S100A proteins in patients with bulky stage IB-IIA cervical cancer treated with neoadjuvant chemotherapy.免疫组织化学检测 Annexin A2 和 S100A 蛋白在接受新辅助化疗的巨块型 Ib-IIA 期宫颈癌患者中的表达。
Gynecol Oncol. 2012 Jul;126(1):140-6. doi: 10.1016/j.ygyno.2012.04.005. Epub 2012 Apr 6.
10
Variation of PD-L1 expression in locally advanced cervical cancer following neoadjuvant chemotherapy.局部晚期宫颈癌新辅助化疗后 PD-L1 表达的变化。
Diagn Pathol. 2020 Jun 3;15(1):67. doi: 10.1186/s13000-020-00977-1.

引用本文的文献

1
Overexpression and biological function of PRDX6 in human cervical cancer.PRDX6在人宫颈癌中的过表达及生物学功能
J Cancer. 2020 Feb 10;11(9):2390-2400. doi: 10.7150/jca.39892. eCollection 2020.
2
Effects of Galectin-1 on Biological Behavior in Cervical Cancer.半乳糖凝集素-1对宫颈癌生物学行为的影响
J Cancer. 2020 Jan 14;11(6):1584-1595. doi: 10.7150/jca.38538. eCollection 2020.
3
Up-regulation of peroxiredoxin-1 promotes cell proliferation and metastasis and inhibits apoptosis in cervical cancer.过氧化物还原酶-1的上调促进宫颈癌细胞增殖和转移并抑制其凋亡。
J Cancer. 2020 Jan 1;11(5):1170-1181. doi: 10.7150/jca.37147. eCollection 2020.
4
Expression of thioredoxin 1 and peroxiredoxins in squamous cervical carcinoma and its predictive role in NACT.硫氧还蛋白 1 和过氧化物酶在宫颈鳞癌中的表达及其在新辅助化疗中的预测作用。
BMC Cancer. 2019 Aug 30;19(1):865. doi: 10.1186/s12885-019-6046-x.
5
The Role of Galectins in Tumor Progression, Treatment and Prognosis of Gynecological Cancers.半乳糖凝集素在妇科癌症进展、治疗及预后中的作用
J Cancer. 2018 Nov 25;9(24):4742-4755. doi: 10.7150/jca.23628. eCollection 2018.
6
Decreased expression of peroxiredoxin1 inhibits proliferation, invasion, and metastasis of ovarian cancer cell.过氧化物还原酶1表达降低抑制卵巢癌细胞的增殖、侵袭和转移。
Onco Targets Ther. 2018 Nov 2;11:7745-7761. doi: 10.2147/OTT.S175009. eCollection 2018.
7
Predictive role of galectin-1 and integrin α5β1 in cisplatin-based neoadjuvant chemotherapy of bulky squamous cervical cancer.Galectin-1 和整合素 α5β1 在基于顺铂的新辅助化疗治疗巨块型宫颈鳞癌中的预测作用。
Biosci Rep. 2017 Sep 27;37(5). doi: 10.1042/BSR20170958. Print 2017 Oct 31.
8
PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer.丙酮酸激酶M2通过与宫颈癌中的mTOR信号通路相互作用增强对顺铂的化疗敏感性。
Sci Rep. 2016 Aug 5;6:30788. doi: 10.1038/srep30788.
9
Molecular mechanisms of cisplatin resistance in cervical cancer.宫颈癌顺铂耐药的分子机制
Drug Des Devel Ther. 2016 Jun 7;10:1885-95. doi: 10.2147/DDDT.S106412. eCollection 2016.

本文引用的文献

1
Galectin 1 expression is associated with tumor invasion and metastasis in stage IB to IIA cervical cancer.半乳糖凝集素 1 的表达与 IB 期至 IIA 期宫颈癌的肿瘤侵袭和转移相关。
Hum Pathol. 2013 Jan;44(1):62-8. doi: 10.1016/j.humpath.2012.04.010. Epub 2012 Aug 30.
2
A novel radioresistant mechanism of galectin-1 mediated by H-Ras-dependent pathways in cervical cancer cells.一种新型的 galectin-1 介导的放射抵抗机制,涉及宫颈癌 H-Ras 依赖性通路。
Cell Death Dis. 2012 Jan 12;3(1):e251. doi: 10.1038/cddis.2011.120.
3
Peroxiredoxin 6 overexpression attenuates cisplatin-induced apoptosis in human ovarian cancer cells.过氧化物酶 6 过表达减轻顺铂诱导的人卵巢癌细胞凋亡。
Cancer Invest. 2011 Jan;29(1):21-8. doi: 10.3109/07357907.2010.535056.
4
Proteomic analysis of cisplatin resistance in human ovarian cancer using 2-DE method.二维电泳法分析人卵巢癌顺铂耐药的蛋白质组学。
Mol Cell Biochem. 2011 Feb;348(1-2):141-7. doi: 10.1007/s11010-010-0648-6. Epub 2010 Nov 16.
5
Identification of up- and down-regulated proteins in gemcitabine-resistant pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry.使用二维凝胶电泳和质谱技术鉴定吉西他滨耐药胰腺癌细胞中的上调和下调蛋白。
Anticancer Res. 2010 Sep;30(9):3367-72.
6
Treatment of stage IB2, IIA bulky cervical cancer: a single-institution experience of neoadjuvant chemotherapy followed by radical hysterectomy and primary radical hysterectomy.IB2 期、IIA 期大块宫颈癌的治疗:新辅助化疗后根治性子宫切除术和原发性根治性子宫切除术的单中心经验。
Arch Gynecol Obstet. 2011 Aug;284(2):477-82. doi: 10.1007/s00404-010-1685-9. Epub 2010 Sep 28.
7
Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells.Anxa2 在增强多药耐药人乳腺癌细胞的侵袭性方面发挥着关键作用。
J Proteome Res. 2009 Nov;8(11):5041-7. doi: 10.1021/pr900461c.
8
Peroxiredoxin I plays a protective role against cisplatin cytotoxicity through mitogen activated kinase signals.过氧化物还原酶 I 通过有丝分裂原激活的激酶信号发挥对抗顺铂细胞毒性的保护作用。
Oral Oncol. 2009 Dec;45(12):1037-43. doi: 10.1016/j.oraloncology.2009.07.002. Epub 2009 Aug 18.
9
Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5-fluorouracil resistance.具有5-氟尿嘧啶抗性的人结肠癌细胞分泌蛋白中糖酵解酶的上调。
Electrophoresis. 2009 Jun;30(12):2182-92. doi: 10.1002/elps.200800806.
10
Comparative study of neoadjuvant chemotherapy before radical hysterectomy and radical surgery alone in stage IB2-IIA bulky cervical cancer.IB2 期到 IIA 期巨块型宫颈癌根治性子宫切除术前行新辅助化疗与单纯根治性手术的对比研究。
J Gynecol Oncol. 2009 Mar;20(1):22-7. doi: 10.3802/jgo.2009.20.1.22. Epub 2009 Mar 31.

大体积 IB-IIA 期鳞癌新辅助化疗相关蛋白的蛋白质组学鉴定。

Proteomic identification of neoadjuvant chemotherapy-related proteins in bulky stage IB-IIA squamous cervical cancer.

机构信息

1Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical College, Wenzhou, China.

出版信息

Reprod Sci. 2013 Nov;20(11):1356-64. doi: 10.1177/1933719113485291. Epub 2013 Apr 18.

DOI:10.1177/1933719113485291
PMID:23599374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3795422/
Abstract

OBJECTIVE

The aim of this study was to investigate the effect of neoadjuvant chemotherapy (NAC) on the human squamous cervical cancer using proteomics profiling and to obtain related proteins to NAC exposure and response.

METHODS

Paired samples of early-stage bulky squamous cervical cancer before and after NAC treatment from patients who responded to NAC were obtained and submitted to 2-dimensional gel electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MS). The expression and localization of the interesting proteins in additional paired samples were confirmed by Western blot analysis and immunohistochemistry.

RESULTS

The comparison of the proteins present before and after NAC revealed that 116 protein spots were significantly changed. In all, 31 proteins were analyzed by MS, and 15 proteins were upregulated in the cancer tissue after NAC relative to the level before NAC, whereas 16 proteins were downregulated after NAC. The significantly higher expression of peroxiredoxin 1 and significantly lower expression of galectin 1 after NAC treatment were confirmed by Western blot.

CONCLUSIONS

Proteomics can be used to identify the NAC-related proteins in squamous cervical cancer. The change in proteins may be associated with NAC exposure and response, but insight into their relevance requires further study.

摘要

目的

本研究旨在通过蛋白质组学分析探讨新辅助化疗(NAC)对人宫颈鳞癌的作用,并获得与 NAC 暴露和反应相关的蛋白。

方法

收集对 NAC 治疗有反应的早期宫颈鳞癌患者 NAC 治疗前后的配对样本,进行二维凝胶电泳和基质辅助激光解吸/电离飞行时间质谱(MS)分析。通过 Western blot 分析和免疫组织化学验证了额外配对样本中感兴趣蛋白的表达和定位。

结果

NAC 前后蛋白质的比较显示,有 116 个蛋白点发生了显著变化。通过 MS 分析了 31 种蛋白质,与 NAC 前相比,NAC 后癌组织中有 15 种蛋白上调,16 种蛋白下调。Western blot 进一步证实了 NAC 治疗后过氧化物酶 1 的表达显著上调,半乳糖凝集素 1 的表达显著下调。

结论

蛋白质组学可用于鉴定宫颈鳞癌中与 NAC 相关的蛋白。蛋白的变化可能与 NAC 暴露和反应有关,但深入了解其相关性还需要进一步研究。